Rapid Tranquillisation for adolescent, adults and older people Medicines management team July 2014

Similar documents
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Assessment of physical monitoring following rapid tranquillisation. Stephen Dye

Guideline for use of Intramuscular Medication for Acutely Disturbed Behaviour in Mental Health and Associated Services

Guidance for Drug Treatment of Acute Behavioural Disturbance (Rapid Tranquillisation)

Emergency Control of the Acutely Disturbed Adult Patient GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT... 2 ACTION...

Guidelines for the use of Zuclopenthixol Acetate (Clopixol Acuphase ) injection. Version 1

Rapid Tranquilisation Policy

Unless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version

Rapid Tranquilisation and the Management of Violent and Aggressive Paediatric Patients

The Rapid Tranquillization Policy. (including the use of oral PRN medication) (Replaces Policy No. 198/Clinical)

Management of Severe Agitation

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]

GUIDANCE FOR THE USE OF ZUCLOPENTHIXOL ACETATE (CLOPIXOL ACUPHASE) IN ADULTS MAY 2017

Rapid Tranquillisation Policy

Sedation Guidelines for Air Ambulance Transfer of Psychiatric Patients

High Dose Antipsychotic Therapy (HDAT) guideline

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Declaration of disclosure. Objectives. Did you know... ED Environment

HIGH DOSE ANTIPSYCHOTIC GUIDELINES (HDAT)

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Guidance on Consent to Treatment Documentation for Medication Patient s Detained under the Mental Health Act

All in service user areas where RT is likely to be used. Rapid, tranquilisation, inpatient, in-patient, ward

ANTIPSYCHOTIC GUIDELINES

Sedative-Hypnotics. Sedative Agents (General Considerations)

PRESCRIBING GUIDELINES

Mental Health Medicines Management Pilot. Community Pharmacy. High Dose Antipsychotic Screening, Education & Advice Service

Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015)

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

High Dose Antipsychotic Medication Policy

Formulary Item Restrictions and/or Advice Site availability

Prescription of High Dose Antipsychotic Medication

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

Chapter 161 Antipsychotics

Elements for a Public Summary

Latuda (lurasidone) Summary of the Risk Management Plan (RMP) for the Public

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS

Delirium. Assessment and Management

Critical Care Pharmacological Management of Delirium

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES

High Dose Antipsychotic Therapy (HDAT) guideline

Elements for a Public Summary. VI.2.1 Overview of disease epidemiology

DEMENTIA AND MEDICATION

DELIRIUM Bridging the gap in Doctors Education

Package leaflet: Information for the user. Tardiben 25 mg tablets. Tetrabenazine

Medication Audit Checklist- Antipsychotics - Atypical

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Aripiprazole Long-Acting Injection (Abilify Maintena ) Guidelines for Prescribing and Administration (Version 3 August 2014)

Elements for a public summary

Drugs that poison the elderly

Part of GP Annual Health Check?

Swiss Summary of the Risk Management Plan (RMP) for Ongentys (opicapone) 50 mg hard capsules

Summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole)

ANTIPSYCHOTICS AGENTS CONVENTIONAL

The legally binding text is the original French version. Opinion 28 May Hospital use (French Social Security Code L )

Clinical. High Dose Antipsychotic Prescribing Procedures. Document Control Summary. Contents

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Managing Behavioural Problems in Patients with Learning Disabilities

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

Datix Ref:

The Maudsley Prescribing Guidelines in

Psychiatric Emergencies and Psychotropic Medication

VI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology

Olanzapine Long Acting Injection (LAI) Guideline

Conduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA)

Delirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen

COALINGA STATE HOSPITAL. Effective Date: August 31, 2006

Behavior Management in Children with Cancer

Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.

Benzodiazepines and Hypnotics

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

Shared Care Guideline for Olanzapine (Zyprexa )

Austedo. (deutetrabenazine) New Product Slideshow

Care of the Acutely Agitated Patient. Objectives. Agitation Defined

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Introduction to Drug Treatment

SHARED CARE GUIDELINE

Supportive Care. End of Life Phase

Management of Delirium in Hospice Patients

PSYCHOTROPIC SOLUTIONS

Factsheet. Buccolam (midazolam) 10mg in 2mL oromucosal solution. Management of seizures in adult patients

PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY

NHS Grampian Guidance For Staff Working In The Mental Health Service For The Use Of High-Dose Antipsychotic Medication

PSYCHOTROPIC SOLUTIONS

Geodon im vs haldol im

Symptom Management Pocket Guides: DELIRIUM

Management of the Agitated and Violent ED Patient. Lauren Klein, MD, MS Faculty Physician Hennepin County Medical Center Minneapolis, Minnesota

The Importance of Taking AUSTEDO (deutetrabenazine) Tablets as Prescribed

Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS:

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tetmodis 25 mg tablets

Version Number: 5. Patient Group Direction drawn up by: Chief Pharmacist - Strategy. Group direction authorised by:

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

ICU Delirium in Infants & Children: Cause for Concern or False Alarm. Objectives

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Initiation of Clozapine Treatment Community Patients

Transcription:

Rapid Tranquillisation for adolescent, adults and older people Medicines management team July 2014

A definition of rapid tranquillisation (RT) The use of medicines to quickly control extreme agitation, aggression and potentially violent behaviour that puts the individual or those around them at risk of physical harm. The aim is to sedate the person to minimise the risk without the person losing consciousness

Aims of RT To reduce suffering to patient To reduce risk of harm to others To do no harm

Our RT guidelines CP 36 & NCP 53 - Rapid Tranquilisation Policy, Version 3 3 sets of guidelines covering different age groups Adolescents 12-18 Adults 18-65 Older adults >65 Available on the trust internet site under clinical guidelines (search for rapid tranq)

Before giving medication Consider non drug approaches De-escalation Time out Check medication given in last 24 hours to ensure that BNF limits are not exceeded Consider other medical conditions Always offer oral first

Trust medicines policy (MCAPP) 41 - Medicines Control, Administration & Prescribing Policy (MCAPP) Oral and IM medications should always be prescribed separately. Abbreviation O/IM should never be used Minimum time intervals should be prescribed Maximum number of doses / daily dose should be recorded CP

Medication used and recommended by the trust in RT Haloperidol Olanzapine Lorazepam Clonazepam IM Promethazine

Maximum daily doses of haloperidol Adults Haloperidol oral 20mg in 24 hours Haloperidol IM 12mg in 24 hours 3mg IM = 5mg oral 1/2 to ¼ the adult dose in elderly

Potential complications of haloperidol in RT Subjective experience of restlessness (akathisia) can worsen agitation Acute muscular rigidity (dystonia) Involuntary movements (dyskinesia) Parkinsonism Excessive sedation QTc prolongation Neuroleptic Malignant Syndrome - NMS

Neuroleptic malignant syndrome Diarrhoe a Profuse Sweatin g High fever Unstable BP & Pulse Mild Muscular rigidity Ataxia Severe Incontinenc e Confusion & altered consciousnes s Convulsion s

Ideally avoid haloperidol if Known cardiac problems Known ECG abnormalities On medicines which prolong QT duration or cause pharmacokinetic interactions Previous severe adverse reaction Neuroleptic naive

When using haloperidol Consider Has this patient had haloperidol before? Will they tolerate it? What is the lowest dose I can use? IM procyclidine should be immediately available to treat a life threatening dystonia The manufacture recommends a pretreatment ECG (association with QTc prolongation)

Olanzapine Adults maximum dose 20mg in 24 hours Elderly same maximum dose as adults but consider a lower initial dose Same maximum for oral and IM i.e. 20mg in 24 hours

Dose of olanzapine IM Adult usual dose 5-10mg Second injection of 5mg-10mg may be given 2 hours after the 1 st injection Elderly 2.5-5mg Maximum 3 injections in 24 hours

Olanzapine IM: administration Reconstitute with 2.1 mls water for injection and rotate vial gently Vial now contains olanzapine as a solution 10mg in 2mls 5mg in 1mls A small amount is retained in the vial Use solution within 1 hour of reconstitution

Pharmacokinetics A dose of 5mg IM olanzapine produced a maximum plasma concentration five times higher than 5mg orally Peak concentrations IM in 15-45 minutes Oral 5-8 hours (tablets AND velotabs)

Calculations practice 1)If olanzapine injection is 5mg in 1ml, how many mg in 2mls 2) How many mls are needed to give a dose of 7.5mg?

Olanzapine IM and benzodiazepines IM Severe bradycardia (and a couple of deaths) associated with giving both IM olanzapine and IM lorazepam IM benzodiazepines should not be given until at least one hour after IM olanzapine Or IM olanzapine not until at least 2 hours after IM lorazepam

Lorazepam Maximum is 4mg in 24 hours oral and IM are the same dose BUT should be written separately Elderly half adult dose On rare occasions higher doses may be required Must consult with a senior Dr first if above 4mg / day Have flumazenil (antidote) immediately available

Administration of IM lorazepam Mix lorazepam 1:1 with water for injections before injecting

Alternatives to IM lorazepam Extensive supply problems with IM lorazepam Alternatives include Olanzapine IM Promethazine IM Clonazepam IM (unlicensed in the UK)

Clonazepam IM Unlicensed in the UK but available as a IV preparation Licensed in New Zealand and Canada as IM IM dose similar to oral 500micrograms 2mg Maximum 4mg in 24 hours Takes longer to work and lasts longer than lorazepam IM In injection cupboard

Administration of IM clonazepam Each pack contains 5 ampoules of clonazepam IM and 5 ampoules of the solvent (water for injection Mix the clonazepam 1:1 with the water for injections before injecting Gives a concentration of 500micrograms /ml Inject immediately

Potential complications of all benzodiazepines in RT Loss of consciousness If respiratory rate falls below <10 breaths / min <90% oxygen saturation (but beware of baseline) = Medical emergency, call for help (use flumazenil IV only or phone for ambulance) Excessive sedation Falls in the elderly

Promethazine Use in benzodiazepine-tolerant patients 25-50mg po or IM repeated if necessary after 1-2 hours Maximum dose 100mg in 24 hours Slow onset of action peak 2-3 hours Can be given with IM haloperidol

Potential complications of antihistamines in RT Excessive sedation Additional antimuscarinic effects Long time to peak so do not expect an immediate effect

Zuclopenthixol acetate (Clopixol acuphase) may be considered only if Past history of repeated parenteral administration Past history of good and timely response Advance directive indicating treatment of choice Clearly expected that patient will be disturbed/violent over extended period of time MUST: consider the additional side effects from any other antipsychotics given over the next 3 days. NOTE: It is NOT rapid

Onset and duration of action of acuphase

Acuphase should never be used for Patients who accept oral medication Patients who are neuroleptic- naïve Patients who are sensitive to EPSE Patients who are unconscious Patients who are pregnant Patients with hepatic or renal impairment Patients with cardiac disease As a punishment for bad behaviour As an alternative to good nursing care

Monitoring using Track and Trigger tool (after IM in adults/elderly but after oral and IM in adolescents) Baseline Temp, Pulse, BP, RR After IM (or oral high dose / any adolescent use) EVERY 15 mins for 1 st hour then hourly for 4 hours Temp, Pulse, BP, RR Depending on clinical status may need to monitor 4 hourly for next 12 hours Use fluid monitoring sheet to ensure adequate hydration and do U and Es if clinically appropriate

Audit results: a cause of concern Parameter 15 minutes Every hour for the 1 st for 4 hours hour Every 4 hours for 48 hours Temperature 38% 50% 50% Pulse 38% 50% n/a BP 38% 63% 50% Risp. Rate 33% 33% n/a

Why do we need to monitor physical health David Rocky Bennett 1960-1998 Died under restraint 1998 Independent enquiry 2003 He had no known physical health concerns Died within 20minutes of restraint During restraint they took his BP once nothing else was measured! No-one was observing his head or respiratory rate

Why do we need to monitor physical health Geoffrey Hodgkins Died within 25 minutes under restraint 2004 Independent enquiry 2006 Previous physical health concerns not investigated No physical observations done until he turned blue!

Monitoring reminder (after IM in adults/elderly but after oral and IM in adolescents) Baseline Temp, Pulse, BP, RR After IM (or oral high dose / any adolescent use) EVERY 15 mins for 1 st hour then hourly for 4 hours Temp, Pulse, BP, RR Depending on clinical status may need to monitor 4 hourly for next 12 hours Use fluid monitoring sheet to ensure adequate hydration and do U and Es if clinically appropriate Make sure PRN has minimum interval between doses

Acuphase monitoring Extended monitoring to fit extended release of drug Separate monitoring form EVERY 4 hours for 72 hours Temp, Pulse, BP, RR Ensure adequate hydration after i.e. 3L of fluid / 24 hours for 72 hours MUST: consider the additional side effects from any other antipsychotics given over the next 3 days.

In adolescents Be aware of unlicensed use and dosage regimes (see guideline ) Adolescents and young adults more sensitive to EPSEs Disinhibition may occur with benzodiazepines Oral chlorpromazine useful in adolescents with PTSD

In older adults Consider other medical conditions Parkinson s disease Delirium Physical cause Alcohol withdrawal Dose usually lower than in adults Increased risk of falls Increased risk of adverse reactions

Pop Quiz 1) I ve just administered IM lorazepam how long should I wait before giving IM olanzapine? 2) What does flumazenil do? 3) How long does zuclopentixol acetate take to peak after administration? 4) What is the maximum daily dose of IM haloperidol? 5) What is the monitoring required following IM clonazepam? 6) How do you reconstitute IM olanzapine? 7) Describe the symptoms of NMS.

Conclusions Exhaust non-drug treatments first Check what other medication has been given in the last 24hrs Always offer oral first Use minimum effective doses Consider if the patient has tolerated the medication before If unsure seek advice Refer to the SHFT guidelines Monitor and record required parameters

References National Institute for Health and Clinical Excellence. Violence: The short-term management of disturbed/violent behaviour in in-patient psychiatric settings and emergency departments Clinical guideline 25. http://www.nice.org.uk. HPT Rapid Tranquilisation Policy (SH CP 48) Version 3. December 2014. Review Date: August 2015